Home
News/PR
Global Clinical Trial Central Lab Services Market

Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Global Clinical Trial Central Lab Services Market Size, Share, Growth & Trends Analysis Report Segmented by Service Type (Safety Testing, Immunology, Biomarker Testing), Phase (Phase I, II, III), Modality, Indication, End-user and Drivers, Challenges and Forecast from 2026 to 2031

Global Clinical Trial Central Lab Services Market Size, Share, Growth & Trends Analysis Report Segmented by Service Type (Safety Testing, Immunology, Biomarker Testing), Phase (Phase I, II, III), Modality, Indication, End-user and Drivers, Challenges and Forecast from 2026 to 2031

The global clinical trial central lab services market size is projected to grow at a CAGR of 7% during the forecast period. This growth is driven by the rising number of clinical trials globally, increasing investments in R&D by pharmaceutical and biotechnology companies, expanding adoption of biomarker-based testing, advancements in genomic and molecular diagnostics, and the integration of digital technologies. To learn more about the research report, download a sample report.

clinical-trial-central-lab-services-market

transparent

600

#12bece

‌
DESCRIPTION
TABLE OF CONTENT
METHODOLODY
SAMPLE DELIVERABLES

Central lab services, also known as clinical trial central lab services, refer to specialized laboratory functions that support clinical trials by conducting standardized testing and analysis of biological samples collected from multiple study sites. Unlike local labs, central labs provide a unified infrastructure for sample management, high-quality testing, and consistent, regulatory-compliant data across global trials. These labs are essential in Phases I–IV of drug development, handling assessments like safety, efficacy, pharmacokinetics (PK), pharmacodynamics (PD), biomarker analysis, and genomic profiling.

Pharmaceutical companies, CROs, and biotech firms rely on central labs to streamline operations and ensure uniform testing protocols across diverse locations. Core services include clinical chemistry, hematology, microbiology, immunology, pathology, and molecular diagnostics. Advanced technologies such as next-generation sequencing (NGS), liquid biopsy, and high-throughput biomarker testing are increasingly incorporated into workflows to advance precision medicine, especially in oncology and rare diseases.

Samples such as blood, urine, saliva, and tissue are collected at trial sites and shipped under controlled conditions to the central lab for standardized testing with validated instruments and quality systems. This centralized approach guarantees consistent data quality, eases regulatory audits, and ensures robust data tracking via laboratory information management systems (LIMS).

Clinical Trial Central Lab Services Market

To learn more about this report, download the PDF brochure

Rising clinical trial volumes are driving demand for centralized lab services to ensure standardized testing and data consistency

The surge in the number of clinical trials in recent years is driven by a shift toward more globalized and complex research, which signifies a fundamental change in trial design, emphasizing large-scale, multi-country studies, adaptive protocols, and precision medicine. According to an article published by the NIH, more than 500,000 clinical studies were registered on ClinicalTrials.gov globally as of April 2025. In this increasingly complex trial environment, central lab services are vital for managing sample logistics, data consistency, and quick test results across various trial sites. These labs provide consistent, high-quality support from safety assessments to advanced biomarker analysis, helping sponsors uphold scientific standards while meeting diverse regulatory requirements.

Additionally, as decentralized and hybrid trial models emerge, centralized labs ensure continuity and reliability, even when samples or data are collected outside traditional clinical sites. As trials expand in scope and scientific detail, dependence on centralized lab infrastructure becomes indispensable for efficient, high-integrity research and accelerated drug development.

Growing preference for decentralized and hybrid trials is increasing the need for central labs to support remote sample collection and real-time data integration

The clinical trial ecosystem is undergoing a significant transformation with the increasing adoption of decentralized and hybrid trial models. These models enable patients to participate remotely through telemedicine, digital health platforms, and home-based testing kits. As a result, central lab service providers are upgrading their services to support logistics, remote sample handling systems, and real-time data management.

The shift toward hybrid trials reduces patient burden, improves recruitment and retention across diverse locations, making trials more inclusive and efficient. To incorporate these transitions, central labs are investing in advanced technologies for remote sample tracking, real-time data sharing, and cloud-based test reporting. Further, lab networks now provide mobile phlebotomy services, direct-to-patient shipment of collection kits, and advanced digital LIMS for real-time sample status updates. Moreover, the integration with electronic data capture (EDC) systems and decentralized clinical trial (DCT) platforms ensures smooth coordination among investigator sites, labs, and sponsors. These capabilities have enabled sponsors and investigators to monitor sample status, access test results in near real time, and maintain data continuity across both physical and virtual trial components. As decentralized models continue to scale, central laboratories remain a cornerstone of trial execution, ensuring that flexibility in trial design, along with maintaining data integrity, compliance, and scientific validity.

Clinical Trial Central Lab Services Market - Segmentation

To learn more about this report, download the PDF brochure

Recent developments in the clinical trial central lab services market

Recent product launches reflect that the central laboratory providers are placing a growing emphasis on technology-enabled services that improve workflow efficiency, real-time sample tracking, and data visibility to better support decentralized, hybrid, and multi-site clinical trial execution. For instance,

In March 2025, IQVIA Laboratories unveiled Site Lab Navigator, an advanced e-Requisition platform that enables investigator sites to submit requisitions electronically, monitor samples in real time, and reduce administrative burden, which are key capabilities designed to support decentralized and hybrid trial logistics
In June 2024, Labcorp introduced Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at streamlining investigator site workflows, improving sample tracking and data integration, and enhancing clinical trial efficiency globally

Competitive Landscape Analysis

The global clinical trial central lab services market is marked by the presence of established and emerging market players, including Thermo Fisher Scientific Inc.; IQVIA; ICON plc; Labcorp; Quest Diagnostics; Charles River Laboratories; Medpace; Frontage Lab; Clarity Laboratories, Inc.; and Novotech, among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Clinical Trial Central Lab Services Market - Key Players

Get a sample report for competitive landscape analysis

Report Scope

Report Metric	Details
Base Year Considered	2025
Historical Data	2024 - 2025
Forecast Period	2026 – 2031
Growth Rate	7%
Market Drivers	Rising number of clinical trials globally Growing investments in R&D by pharma and biotech companies Advancements in biomarker discovery and genomic testing Adoption of digital technologies and AI-enabled tools in lab operations Increased outsourcing to CROs and central labs
Attractive Opportunities	Growing role of central labs in decentralized and hybrid clinical trials Integration of clinical trial data with real-world data and electronic health records Development of specialized lab testing for advanced therapies Expansion into emerging markets
Segment Scope	Service Type, Phase, Modality, Indication, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Thermo Fisher Scientific Inc.; IQVIA; ICON plc; Labcorp; Quest Diagnostics; Charles River Laboratories; Medpace; Frontage Lab; Clarity Laboratories, Inc.; and Novotech; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Clinical Trial Central Lab Services Market Segmentation

This report by Medi-Tech Insights provides the size of the global clinical trial central lab services market at the regional- and country-level from 2024 to 2031. The report further segments the market based on service type, phase, modality, indication, and end-user.

Market Size & Forecast (2024-2031), By Service Type, USD Million

Safety Testing
Immunology
Biomarker Testing
Genomic and Molecular Testing
Pathological Testing
Others

Market Size & Forecast (2024-2031), By Phase, USD Million

Phase I
Phase II
Phase III

Market Size & Forecast (2024-2031), By Modality, USD Million

Small Molecules
Biologics
Cell & Gene Therapy
Others

Market Size & Forecast (2024-2031), By Indication, USD Million

Oncology
Cardiology
Neurology
Infectious Diseases
Immunology & Autoimmune Diseases
Others

Market Size & Forecast (2024-2031), By End-user, USD Million

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Others

Market Size & Forecast (2024-2031), By Region, USD Million

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
Latin America
Middle East & Africa

Key Strategic Questions Addressed

What is the market size & forecast of the clinical trial central lab services market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the clinical trial central lab services market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market?
What are the key strategies adopted by players?

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2026-2027)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Clinical Trial Central Lab Services Market Snapshot (2026-2031)
- Segment Overview
- Regional Snapshot
- Competitive Insights

Market Overview
- Market Dynamics
  - Drivers
    - Rising number of clinical trials globally
    - Growing investments in R&D by pharma and biotech companies
    - Advancements in biomarker discovery and genomic testing
    - Adoption of digital technologies and AI-enabled tools in lab operations
    - Increased outsourcing to CROs and central labs
  - Restraints
    - High operational, logistics and infrastructure costs
    - Data integration challenges across multiple platforms
    - Regulatory complexity arising from region-specific compliance requirements
  - Opportunities
    - Growing role of central labs in decentralized and hybrid clinical trials
    - Integration of clinical trial data with real-world data and electronic health records
    - Development of specialized lab testing for advanced therapies
    - Expansion into emerging markets
  - Key Market Trends
    - Increasing adoption of cloud-based laboratory information systems (LIMS)
    - Growing focus on sustainability and green lab practices
  - Unmet Market Needs
  - Industry Speaks

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Service Type, USD Million
- Introduction
- Safety Testing
- Immunology
- Biomarker Testing
- Genomic and Molecular Testing
- Pathological Testing
- Others

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Phase, USD Million
- Introduction
- Phase I
- Phase II
- Phase III

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Modality, USD Million
- Introduction
- Small Molecules
- Biologics
- Cell & Gene Therapy
- Others

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Indication, USD Million
- Introduction
- Oncology
- Cardiology
- Neurology
- Infectious Diseases
- Immunology & Autoimmune Diseases
- Others

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By End-user, USD Million
- Introduction
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Others

Global Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Region, USD Million
- Introduction
- North America Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Country, USD Million
  - US
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Canada
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Europe Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Country, USD Million
  - UK
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Germany
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - France
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Italy
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Spain
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Rest of Europe
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Asia Pacific (APAC) Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), By Country, USD Million
  - China
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Japan
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - India
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
  - Rest of Asia Pacific
    - Market Size & Forecast, By Service Type (USD Million)
    - Market Size & Forecast, By Phase (USD Million)
    - Market Size & Forecast, By Modality (USD Million)
    - Market Size & Forecast, By Indication (USD Million)
    - Market Size & Forecast, By End-user (USD Million)
- Latin America (LATAM) Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), USD Million
  - Market Size & Forecast, By Service Type (USD Million)
  - Market Size & Forecast, By Phase (USD Million)
  - Market Size & Forecast, By Modality (USD Million)
  - Market Size & Forecast, By Indication (USD Million)
  - Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Clinical Trial Central Lab Services Market Size & Forecast (2024-2031), USD Million
  - Market Size & Forecast, By Service Type (USD Million)
  - Market Size & Forecast, By Phase (USD Million)
  - Market Size & Forecast, By Modality (USD Million)
  - Market Size & Forecast, By Indication (USD Million)
  - Market Size & Forecast, By End-user (USD Million)

Competitive Landscape
- Key Players and their Competitive Positioning
  - Key Player Comparison
  - Segment-wise Player Mapping
  - Market Share Analysis (2025)
  - Company Categorization Matrix
    - Dominants/Leaders
    - New Entrants
    - Emerging Players
    - Innovative Players
  - Key Strategies Assessment, By Player (2023-2025)
    - New Product Launches
    - Partnerships, Agreements, & Collaborations
    - Mergers & Acquisitions
    - Geographic Expansion

Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

Thermo Fisher Scientific Inc.
IQVIA
ICON plc
Labcorp
Quest Diagnostics
Charles River Laboratories
Medspace
Frontage Lab
Clarity Laboratories, Inc.
Novotech
Other Prominent Players

Note: *Indicative list

**For listed companies

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Clinical Trial Central Lab Services Market - Secondary Research

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

Stakeholders from Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others

Breakdown of Primary Interviews

Clinical Trial Central Lab Services Market - Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data

Clinical Trial Central Lab Services Market - Regional Analysis